Hematology

Filter

New Study Links Systemic Sclerosis to Higher Cancer Risk

October 2025

Study links systemic sclerosis to elevated cancer risks, varying by specific autoantibody profiles.

RSV

RSV Vaccine Shows Stronger Response in Immunocompromised Adults

A new study reports that the adjuvanted RSVPreF3 OA vaccine generates stronger immune responses than RSVpreF in immunocompromised adults.

Rapid AI-Driven Leukaemia Diagnosis Revolutionises Treatment Urgency

Innovative AI tool MARLIN classifies leukemia fast and accurately, improving urgent treatment decisions.

agent orange. lymphoma

Genetic Risk and Agent Orange Independently Raise Lymphoma

Study reveals genetics and Agent Orange exposure independently boost lymphoma risk among veterans, highlighting the need for targeted screening and prevention strategies.

lymphoma, breast implant

Breast Anaplastic Large Cell Lymphoma Rates Vary by Race and Ethnicity

New research shows rising rates of breast anaplastic large cell lymphoma among White and Hispanic women, with notable racial and ethnic disparities.

Rob Pieters

Hema Now: Episode 25: The Future of Childhood Cancer

Catherine Glass chats with Rob Pieters, Professor of Pediatric Oncology and co-founder of the Princess Máxima Center, Europe’s largest childhood cancer center.

Konstanze Döhner, President Elect, European Hematology Association (EHA); Department of Internal Medicine III, University Hospital of Ulm, Germany.

EHA Interview 2025: Konstanze Döhner

EMJ spoke with Konstanze Döhner, President Elect of the European Hematology Association, about her priorities for the future of haematology, challenges in research and patient care, and the vision behind the EHA2025 theme “Borderless Hematology”.

Martin Dreyling, Professor of Medicine and Head of the Lymphoma Programme, Ludwig Maximilian University, Germany; Scientific Program Committee Chair EHA2025 European Hematology Association (EHA)

EHA Interview 2025: Martin Dreyling

EMJ spoke with Martin Dreyling, Chair of the EHA2025 Scientific Program Committee, about his career journey, what attendees can expect from the upcoming congress, and the vision behind its programme.

Nivolumab in Patients with Relapsed-Refractory Hodgkin Lymphoma

Up to a quarter of patients with classical Hodgkin’s lymphoma (HL) are resistant or have disease relapse after first-line chemotherapy…

Loading posts...

« Previous 1 2 3 4 … 95 Next »